BMRA
BIOMERICA INC
Key Financials
Gross Profit
$498000
↓ 18.5%
Operating Income
$-5137000
↑ 19.3%
Revenue
$5.3M
↓ 1.9%
Net Income
$-4973000
↑ 16.8%
Total Liabilities
$1.8M
↓ 30.9%
Total Assets
$5.9M
↓ 35.8%
Shareholders' Equity
$4.1M
↓ 37.7%
Cash & Equivalents
$2.4M
↓ 42.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 4/13/2026 | View on SEC |
| S-8 | 2/27/2026 | View on SEC |
| 4 | 1/28/2026 | View on SEC |
| 10-Q | 1/14/2026 | View on SEC |
| 4 | 12/31/2025 | View on SEC |
| 4 | 12/31/2025 | View on SEC |
| 4 | 12/31/2025 | View on SEC |
| 4 | 12/31/2025 | View on SEC |
| 4 | 12/31/2025 | View on SEC |
| 8-K | 12/16/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BMRA |
| Company Name | BIOMERICA INC |
| CIK | 73290 |
| Sector | In Vitro & In Vivo Diagnostic Substances |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2835 |
| SIC Description | In Vitro & In Vivo Diagnostic Substances |
| Entity Type | operating |
| Fiscal Year End | 0531 |
| State of Incorporation | DE |
| Phone | 9493792875 |